Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 207611
Company: NOVELGENIX THERAPS
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
VALPROIC ACID VALPROIC ACID 250MG CAPSULE;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
08/05/2019 ORIG-1 Approval STANDARD

Label is not available on this site.

VALPROIC ACID

CAPSULE;ORAL; 250MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
VALPROIC ACID VALPROIC ACID 250MG CAPSULE;ORAL Prescription No AB 073484 BIONPHARMA INC
VALPROIC ACID VALPROIC ACID 250MG CAPSULE;ORAL Prescription No AB 073229 CATALENT
VALPROIC ACID VALPROIC ACID 250MG CAPSULE;ORAL Prescription No AB 207611 NOVELGENIX THERAPS
VALPROIC ACID VALPROIC ACID 250MG CAPSULE;ORAL Prescription No AB 091037 SUN PHARM INDS LTD

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English